Mirae Asset Global Investments Co., Ltd. Enanta Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 826 shares of ENTA stock, worth $6,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
826
Previous 714
15.69%
Holding current value
$6,062
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ENTA
# of Institutions
113Shares Held
18.8MCall Options Held
5.6KPut Options Held
13.9K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$15.6 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.12MShares$15.5 Million6.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$14.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$13.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.35MShares$9.89 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $152M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...